RFP
CHRS icon

Root Financial Partners’s Coherus Oncology CHRS Stock Holding History

Root Financial Partners’s Portfolio CHRS Stock Details CHRS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$336 Buy
+199
New +$353 ﹤0.01% 2993

Other funds holding CHRS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
SB
Samsara BioCapital Palo Alto, California $1.03B AUM 214.94% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
KKRC
Kohlberg Kravis Roberts & Co New York $5.35B AUM 63.01% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
CM
CM Management Gulf Breeze, Florida $120M AUM 37.12% 1-Year Est. Return
CWG
C WorldWide Group Copenhagen, Denmark $4.66B AUM 11.67% 1-Year Est. Return

Root Financial Partners's CHRS Position: Q1 2026 in Review

Root Financial Partners opened a new position in Coherus Oncology (CHRS) in Q1 2026: 199 shares worth $336. The stake represents ﹤0.01% of the portfolio and ranks #2993 among its holdings.

157 funds tracked by Wall St. Rank hold CHRS as of Q1 2026.

  • Root Financial Partners held 199 shares of Coherus Oncology worth $336 as of Q1 2026.
  • Coherus Oncology was a new Root Financial Partners position in Q1 2026.
  • Coherus Oncology made up ﹤0.01% of Root Financial Partners's portfolio in Q1 2026, its #2993 holding.
  • 157 funds tracked by Wall St. Rank held Coherus Oncology as of Q1 2026.

Based on Root Financial Partners's 13F filing for Q1 2026, filed 24 Apr 2026.